Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-6-11
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1476-5551
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1273-4
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17989711-Adult, pubmed-meshheading:17989711-Aminoglycosides, pubmed-meshheading:17989711-Antibodies, Monoclonal, pubmed-meshheading:17989711-Antibodies, Monoclonal, Humanized, pubmed-meshheading:17989711-Antineoplastic Agents, pubmed-meshheading:17989711-Chromosomes, Human, Pair 7, pubmed-meshheading:17989711-Female, pubmed-meshheading:17989711-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:17989711-Humans, pubmed-meshheading:17989711-Immunotoxins, pubmed-meshheading:17989711-Leukemia, Myeloid, Acute, pubmed-meshheading:17989711-Lymphocyte Transfusion, pubmed-meshheading:17989711-Myeloid-Lymphoid Leukemia Protein, pubmed-meshheading:17989711-Neoplasm Recurrence, Local, pubmed-meshheading:17989711-Oncogene Proteins, Fusion, pubmed-meshheading:17989711-Time Factors, pubmed-meshheading:17989711-Tissue Donors, pubmed-meshheading:17989711-Translocation, Genetic, pubmed-meshheading:17989711-Transplantation, Homologous
pubmed:year
2008
pubmed:articleTitle
Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion.
pubmed:publicationType
Letter, Case Reports